Columbia Care, a global medical cannabis leader, provides a closer look at CBD as a medicine, its limitations, potential and future applications.
The beneficial properties that the cannabis and hemp plants impart are due predominantly to phytocannabinoids, a group of naturally occurring, biologically active chemical compounds. The two most abundant are cannabidiol (CBD) and delta-9-tetrahydrocannbinol (THC). But can these compounds help us understand CBD as a medicine?
Science has taught us that if these plant-produced phytocannabinoids are ingested, they act on the same cannabinoid receptors as the endocannabinoids that the body makes itself. The endocannabinoid system (ECS) is comprised of receptors on cells throughout the body that are bound by natural endocannabinoids, leading to biological downstream effects that may prove beneficial for certain medical conditions. Endocannabinoids can have positive effects in cardiovascular and respiratory disorders, musculoskeletal disorders and neurological disorders, specifically epilepsy (Pacheret al., 2008).
The current state of CBD
... read more at: https://www.healtheuropa.eu/cbd-as-a-medicine/91259/